The ChemoFx Assay is a laboratory-developed test and has not been cleared or approved by the U.S. Food and Drug Administration.

Flahy uses knowledge graphs to connect biological and clinical data, supporting personalized decisions in AI-powered ...

Putrajaya has been urged to review Budget 2027 allocations to strengthen elderly care and welfare, including for those who ...

Major AI players are already moving deeper into healthcare. Microsoft and Mayo Clinic are developing a frontier AI model ...

Peptides themselves are nothing new. They’re short chains of amino acids that perform important functions throughout the body ...

Humana stock surges 15% in premarket trading as Medicare Advantage Star Ratings improve dramatically, with 95% of members now ...

What is the best time to begin medicaid planning for long-term care? HelloNation answers that question in an article featuring insights ...

According to Sundar Pichai, The Lancet published Google’s AMIE trial showing 90% diagnosis match and 75% clinician prep gains in urgent care.

Neko Health promises advanced body imaging and blood testing for $500. Is it worth it?

Rooz emphasizes "cemented" blockchain workflows (e.g., Canton Network's repo settlements, DTCC's tokenized Treasury trades) ...

October 29–30 multidisciplinary executive summit connects clinical care, life sciences, public health, AI, policy, ...